Japan is one of the world's leading healthcare markets with strong research and development environments and large global pharmaceutical and investment companies. It has therefore been identified as a priority market by the Norwegian industry for increased export efforts.
Programme
- Introduction to the Japanese market and Innovation Norway's export efforts
- The Nordic Health Summit in Japan is a good opportunity to get to know the market and make contact with customers, partners and investors. It is being held for the 4th time during OsakaEXPO2025.
- NEC Bio / NEC OncoImmunity activities for precision medicine via Japan-Norway collaboration by Hugues Fontenelle, Senior manager, NEC Bio's PCV (Personalized Cancer Vaccines) group
- Q&A
Organizer: Innovation Norway